ACSL4 and colorectal cancer: The patients with high expression of ACSL4 have poor prognosis in colorectal cancer (OS: total number, 177; 95% CI, 1.36–3.28, HR, 2.11; Cox P, 0.000896,433; DSS: total number, 177; 95% CI, 1.19–3.25, HR, 1.96; Cox P, 0.00877,945).